Equities

Ion Beam Applications SA

Ion Beam Applications SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)13.02
  • Today's Change-0.22 / -1.66%
  • Shares traded5.33k
  • 1 Year change-18.42%
  • Beta0.9702
Data delayed at least 15 minutes, as of Apr 19 2024 10:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

  • Revenue in EUR (TTM)428.72m
  • Net income in EUR-9.11m
  • Incorporated1986
  • Employees1.85k
  • Location
    Ion Beam Applications SAChemin du Cyclotron 3LOUVAIN-LA-NEUVE 1348BelgiumBEL
  • Phone+32 10475811
  • Fax+32 10475810
  • Websitehttps://iba-worldwide.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
IBAB:BRU since
announced
Transaction
value
Radcal CorpAnnounced08 Feb 202408 Feb 2024Announced32.05%--
Data delayed at least 15 minutes, as of Apr 19 2024 10:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Detection Technology Oyj-100.00bn-100.00bn202.98m478.00--2.79----------4.97----------9.34--11.96--47.44--8.223.13--0.08153.455.292.027.55-18.03-14.88-9.55
Semperit Holding AG721.08m25.13m241.53m4.58k9.560.56793.870.3351.23-0.816235.1720.670.80984.688.24157,578.902.795.253.607.3222.4624.793.455.591.384.920.342686.85-7.54-3.87-34.59---7.21--
Tristel Plc46.14m7.05m258.03m213.0037.017.0825.815.590.12560.12560.82190.65670.9921.516.26185,394.4015.178.8617.1010.2482.5980.6315.2910.633.93411.730.1605109.9915.7010.14351.986.409.8818.05
Nyxoah SA4.35m-43.21m259.10m147.00--2.64--59.59-1.55-1.550.15553.420.03220.78912.0629,618.53-31.98-23.73-35.88-25.9861.9162.42-993.86-1,469.594.50--0.1147--40.99---38.39--100.58--
BICO Group AB192.73m-145.35m266.39m884.00--0.6508--1.38-23.61-27.6631.6069.180.24872.243.062,545,136.00-18.77---20.89--52.34---75.47--1.91-1.050.2852--6.09---1,889.33------
Medistim ASA44.78m8.83m282.36m152.0031.898.3226.046.315.685.6828.7721.771.070.86465.983,462,921.0021.0122.9326.1428.5278.6778.2519.7220.642.61--0.042575.257.0010.06-8.9112.720.03314.87
Lumibird SA203.56m7.13m313.41m1.05k39.201.6212.811.540.35590.35599.148.620.52381.094.05193,497.101.833.132.443.9961.6861.763.505.891.622.470.42870.006.6015.12-37.23-2.4718.34--
COLTENE Holding AG249.97m12.30m327.38m1.20k26.583.2816.911.312.002.0040.6216.211.331.406.58201,937.606.5310.4810.9018.7464.2462.684.927.470.80455.620.317279.94-9.133.54-54.05-6.81-7.72-7.79
IVF Hartmann Holding AG152.36m15.60m338.60m304.0021.712.1715.912.226.316.3161.6363.070.80153.088.46486,687.508.217.299.998.9053.9053.2910.248.303.89--0.005652.16-1.792.0934.951.49-14.8326.82
Ion Beam Applications SA428.72m-9.11m400.94m1.85k--3.63166.290.9352-0.313-0.31314.733.650.7022.542.73---1.491.55-5.924.3231.3635.23-2.122.380.71030.94170.281443.0618.6710.74-250.40---8.06--
Avon Protection PLC229.07m-15.41m418.23m928.00--2.86101.171.83-0.4397-0.38616.544.130.70052.635.48211,270.60-4.71-1.07-5.39-1.2935.2335.51-6.73-1.621.802.920.3822---7.481.85-387.72---1.66-7.86
Safilo Group SpA1.02bn-24.65m446.04m3.83k--1.1815.310.4353-0.0596-0.05962.480.91651.131.804.91267,693.80-2.87-7.06-4.47-11.3057.1652.70-2.55-6.871.101.940.2848---4.832.39-145.51---15.50--
CellaVision AB58.02m11.16m449.50m228.0040.277.3230.857.755.465.4628.4030.040.74411.606.932,970,575.0014.3215.3016.6218.2468.3769.0319.2419.982.0159.030.0828110.185.9413.1710.128.0030.458.45
Advanced Medical Solutions Group plc147.46m18.56m468.25m800.0025.461.6415.023.180.07240.07240.57551.120.44261.755.34--5.576.546.047.0655.5756.7512.5914.824.00--0.036125.831.514.23-22.14-6.7115.6612.32
Stratec SE261.91m13.07m486.92m1.52k37.262.0915.831.861.071.0721.5419.190.60621.514.45172,083.403.027.073.698.2024.7627.324.999.701.095.380.39440.81-4.636.88-55.293.30-2.16-7.68
Data as of Apr 19 2024. Currency figures normalised to Ion Beam Applications SA's reporting currency: Euro EUR

Institutional shareholders

22.52%Per cent of shares held by top holders
HolderShares% Held
Premier Fund Managers Ltd.as of 30 Nov 20231.86m6.14%
Belfius Insurance SA NVas of 31 Dec 20221.19m3.93%
Van Lanschot Kempen Investment Management NVas of 31 Dec 2022875.39k2.89%
Paladin Asset Management Investmentaktiengesellschaft TGVas of 31 Dec 2022768.77k2.54%
BNP Paribas Asset Management Belgium SAas of 29 Feb 2024552.43k1.82%
NS PARTNERS EUROPE SAas of 01 Feb 2024430.66k1.42%
Investor Asset Management BVas of 05 Apr 2024430.36k1.42%
Fidelity Management & Research Co. LLCas of 29 Feb 2024350.60k1.16%
Norges Bank Investment Managementas of 13 Feb 2024186.22k0.62%
Dimensional Fund Advisors LPas of 04 Apr 2024177.17k0.59%
More ▼
Data from 31 Dec 2022 - 11 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.